Deliver Your News to the World

Medical Foods Industry Conference to take place August 6 in Miami

With a distinct, FDA-regulated category, the MFICE conference is the only venue for medical foods executives to meet and network. The convention will cover R&D, outreach, clinical research studies, market standards, opportunities for market growth and other important topics.


Tampa / FL / United States – WEBWIRE
Medical Foods Industry Conference and Expo - August 6, 2015 - Miami Beach
Medical Foods Industry Conference and Expo - August 6, 2015 - Miami Beach

Marketdata Enterprises, Inc. and Ticonderoga Ventures  announce the Medical Foods Industry Conference & Expo (MFICE).   MFICE is an intensive 2-day conference on the medical foods market taking place August 6, 2015 in Miami.  
 
The emerging medical foods market is USD $1.3 billion annually with strong growth potential. MFICE is the industry’s first organization providing a venue for the market’s innovators and thought leaders to meet, network, and discuss the industry’s strategies, regulations and growth.
 
The goal of MFICE is to generate new ideas and collaboration between various entities. Discussions of R&D, outreach, clinical research studies, market standards for products, retail versus prescription channels, current usage by various healthcare professionals and facilities, opportunities and obstacles for market growth, and insurance coverage are some of the topics that will be covered at this important summit.
 
As a distinct, FDA-regulated category, medical foods are gaining more widespread acceptance.  However, they remain poorly understood by patients, pharmacists and physicians.  Dieticians and nurses are generally familiar with medical foods. This is the ONLY place where medical foods market professionals can meet.
 
MFICE will cover these topics:

  •     Status of the U.S. medical foods market, trends, market size, competitors, growth prospects.
  •     Existing products, how they are used for specific diseases/conditions, by various manufacturers.
  •     Regulation of medical foods by the FDA.
  •     Legal Aspects: Claims, ingredients, definition of Medical Foods, case studies, actions, regulatory bodies.
  •     The usage of medical foods by dieticians and physicians and healthcare facilities.
  •     Pharmacists’ use of Medical Foods to form a business, pharmacist entrepreneurs.
  •     How retail pharmacies deal with mfrs. and customers, demand, pricing, etc.
  •     How insurance companies treat medical foods: outcomes, clinical data, ACA implications.
  •     The current venture capital environment for Medical Foods.



Speakers include executives from Primus Pharmaceuticals Management, Targeted Medical Pharma, Metagenics, as well as others. At least 5 major manufacturers of medical foods will be presenting, plus pharmacists, attorneys and others.

Video: http://youtu.be/c93CzCrR-NQ

For more information, please visit the website www.mfice.com or contact:
 
Marketdata Enterprises, Inc.
Phone: 813-907-9090
Fax: 813-907-3606
 
 
ABOUT MARKETDATA ENTERPRISES, INC.
 
Marketdata Enterprises is a 35-year analyst of various healthcare and niche markets, since 1989. The company publishes multi-client market and industry studies, performs custom research and consulting projects, holds teleconferences, seminars, and has independently tracked a wide variety of healthcare sectors, including medical foods, medical labs, pain management programs, medical marijuana, fertility clinics, weight loss programs, medical spas, and the insomnia market, among others.
 
 
ABOUT TICONDEROGA VENTURES, INC.
 
Started in 2000, Ticonderoga Ventures, Inc. is a company that provides consulting, event logistics, software and marketing.  The company specializes in niche events and products.
 
Ticonderoga Ventures, Inc.
Media, Marketing and Logistics Representative
Tel/ Fax: USA +1 (212) 722-1744 ext 89
 
This press release may contain forward-looking statements, particularly as related to the business plans of the company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by these sections. Actual results may differ materially from the company’s expectations and estimates.
 


( Press Release Image: https://photos.webwire.com/prmedia/32265/198335/198335-1.png )


WebWireID198335




 
 Medical Foods
 pharmaceuticals
 conference
 Primus Pharmaceuticals
 Metagenics


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.